Part of being a responsible corporate citizen and business partner is promoting diversity not only within our operations but also among those with whom we conduct business. We are committed to actively working to build and maintain relationships with qualified small businesses as well as veteran-, minority-, LGBT-, disabled-, and women owned enterprises. We establish strong relationships with advocacy partners and certifying bodies that promote diverse and small business suppliers and participate in various events and conferences to increase the opportunity for matchmaking.
In 2021, we established our Corporate Supplier Diversity Policy, reinforcing our commitment to supplier diversity and formalizing the program’s objectives and expectations. We also developed and completed mandatory internal training for our procurement and sourcing specialists in the US. These colleagues play a critical role in upholding our policy and executing our plans. To maintain the integrity of our program, we only account for spending with diverse and small suppliers certified through a third party or registered with the Small Business Administration (SBA). We support data quality by engaging with a supplier diversity solution partner to validate the supplier’s certification status.
By continually increasing the diversity of our world-class supply chain, we benefit by obtaining the value of the innovative solutions and the fresh business perspective such firms have to offer. They in essence become our partners in maintaining our position as a leader in our industry, allowing us to ensure our customers’ success.
Value received is only part of the story. Just as important, by working to expand the field of opportunity, we help create the conditions that stimulate economic growth in the communities where we, our customers, and our colleagues live and do business. We know that when this happens, everyone wins.
We are committed to employing proper Global Citizenship practices in all of our business relationships. As such, we expect all suppliers to conduct their worldwide operations in a manner consistent with sustainability and socially responsible business practices and policies. While recognizing differences in laws, customs and acceptable practices around the world, we believe shared values are the cornerstone of supplier relationships. Therefore, we expect suppliers and all supplier sub-contractors to be fully compliant with our Supplier Code of Conduct. Our supplier contracts state that we reserve the right to audit suppliers on all elements of this Code and to terminate a business relationship if it is determined that a supplier is in violation.
To build upon our supply chain due diligence processes, this year we implemented a supply chain risk management program to map, monitor, and lower our supply chain risk based on supplier performance, geographic exposure, and environmental practices. In addition, we use the globally recognized EcoVadis platform to assess and help drive improvements in our suppliers’ health and safety, labor, and sustainability performance, and to monitor compliance with our Supplier Code of Conduct.
As part of this commitment, we adhere to the Conflict Minerals provision of the Dodd-Frank Act. Access to additional related documentation is below:
Thermo Fisher Scientific is fully committed to acting ethically and with integrity, combatting slavery and human trafficking across our global operations.
This statement is made pursuant to section 54(1) of the UK Modern Slavery Act 2015 and the reporting requirements under the Australian Modern Slavery Act 2018 (Cth) (the "Acts") and constitutes our slavery and human trafficking statement for the financial year ending 31 December 2020. It is intended to provide our customers, stakeholders and investors with information on the systems and controls that we implement to ensure slavery and human trafficking is not taking place in our supply chain.
Our previous Modern Slavery and Human Trafficking statements are available here.
Thermo Fisher Scientific is fully committed to acting ethically and with integrity, combatting slavery and human trafficking across our global operations.
This statement is made pursuant to section 54(1) of the UK Modern Slavery Act 2015 and the reporting requirements under the Australian Modern Slavery Act 2018 (Cth) (the "Acts") and constitutes our slavery and human trafficking statement for the financial year ending 31 December 2021. It is intended to provide our customers, stakeholders and investors with information on the systems and controls that we implement to ensure slavery and human trafficking is not taking place in our supply chain.
Our previous Modern Slavery and Human Trafficking statements are available here.
Thermo Fisher Scientific Inc., as parent company of the Thermo Fisher Scientific group of companies ("Thermo Fisher Scientific" or the “Group”), issues this statement on behalf of itself and each of its subsidiaries that are subject to the Acts and in particular its UK and Australian subsidiaries listed in the Appendix.
Thermo Fisher Scientific is the world leader in serving science. Our Mission is to enable our customers to make the world healthier, cleaner and safer. We serve customers working in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental, industrial quality and process control settings. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
On December 8, 2021, the company acquired PPD, Inc., a leading global provider of clinical research services to the pharma and biotech industry.
Following the acquisition, the PPD group is in the process of being integrated into Thermo Fisher with the aim of consolidating group policies in the area of supply chain management, risk management, and employee training to support responsible business practices and further mitigate modern slavery risks. Due to the timing of the acquisition (December 8, 2021), PPD Global Ltd and Synexus Clinical Research Ltd (‘PPD’) have published separate Modern Slavery Statements for the financial year ending 31 December 2021. Click here for PPD Global Ltd and here for Synexus Clincal Research Ltd.
For more information, please visit here.
Thermo Fisher Scientific is committed to ensuring that we conduct our global business with respect for human rights and in compliance with applicable laws and fair labor practices, as evidenced by the following policies:
Thermo Fisher Code of Business Conduct and Ethics (the “Code”) applies to all Thermo Fisher employees and sets forth our commitment to conduct business with the highest ethical standards and to comply with all applicable laws and regulations.
All employees receive compulsory annual training on the importance of acting ethically and with integrity in every area of our business. Further, employees are required to promptly report any known or suspected breach of Thermo Fisher's Code of Business Conduct or other illegal or unethical behaviour.
We offer a number of resources such as our confidential Ethics Hotline, a telephone and web-based hotline maintained by a third party for the purpose of gathering information regarding compliance and ethics concerns. The Ethics Hotline is available to all employees to raise all forms of concern they may have, anonymously if requested, including those relating to human rights issues. Therefore, if there are any concerns these can be raised in confidence and without fear of retaliation.
Reports to Thermo Fisher Scientific's Ethics Hotline of violations of law, the Code, or other Thermo Fisher Scientific policies are rigorously investigated.
Through our supply chain, we source components that are used both at Thermo Fisher Scientific facilities and by our external partners to manufacture our products. We purchase goods and services from thousands of suppliers around the globe. As a result, our supply chain is global and complex.
Thermo Fisher Scientific expects suppliers to treat their employees with dignity and respect and to comply with all legal and regulatory requirements pertaining to the fair treatment of employees. We are committed to implementing effective systems and controls to ensure that our suppliers recognize our position in relation to compliance with all applicable laws and regulations, including those relating to the prohibition of slavery and human trafficking.
Thermo Fisher Scientific has four key corporate values - Integrity, Intensity, Innovation, and Involvement. These four values form the foundation of our business. We believe shared values are the cornerstone of supplier relationships, therefore, we expect that our suppliers and their subcontractors hold these same values and act fully in compliance with our Supplier Code of Conduct.
More information about our supply chain can be found here.
Our Supplier Code of Conduct outlines expectations that we have for all of our suppliers. These are in line with our corporate values and include:
We reserve the right to audit suppliers on all elements of their compliance with the Supplier Code of Conduct and to terminate a business relationship if it is determined that a supplier is in violation.
We have robust supply chain due diligence and audit processes in place as part of our corporate commitment to supply chain compliance and, in particular, responsible sourcing of materials used in our products. Further details are available for review here.
In 2021, we conducted detailed risk assessments, working with our Global Sourcing function and a third-party partner, Assent Compliance Inc. (“Assent”), to identify the suppliers that we believe are exposed to the highest risk of modern slavery and human trafficking.
In 2020, we retained general focus on reviewing, via Assent, suppliers in countries which, according to the Global Slavery Index, have high rates of forced labor practices. We focused specifically on significant suppliers in Asia-Pacific and India. In these higher risk countries, we conducted diligence utilizing a questionnaire based on the Slavery and Trafficking Risk Template (“STRT”). This is a standard template that was created by the Social Responsibility Alliance and is used by more than 10,000 companies as part of their supplier governance programs. More information on the STRT is available here.
We also expanded our diligence processes for suppliers to our Fisher Scientific business, a sales channel for a large number of third-party manufacturers as well as our internally manufactured products. Fisher Scientific worked during 2021 to ensure a targeted approach to higher risk supplies. By way of example, when procuring higher risk PPE products (including nitrile gloves) in regions with higher risk for forced labor, for which there was increased demand during the COVID-19 pandemic, Fisher Scientific mandated the provision of documentary evidence substantiating that the manufacturing locations utilized for the products in question were properly operated in accordance with International Labor Organization Standards.
In addition to diligence efforts led by Assent and our Global Sourcing function which specifically target higher risk jurisdictions and categories of product, we employ EcoVadis SAS (“EcoVadis”) to assess the ethics, environmental practices and labor and human rights status of direct suppliers across the world with whom we have a material spend. This initiative will see EcoVadis target the top 80% of our direct sourcing spend by 2025. While not uniquely focused on forced labor, we are able to obtain useful indicators of responsible practices via this diligence. In 2021, all suppliers participating in the EcoVadis program from high risk geographies were screened on the Labor and Human Rights theme, with no high-risk findings.
Compliance training is regularly undertaken by all employees. All directors, officers and employees of Thermo Fisher Scientific are also responsible for reviewing the Code and confirming annually that they will comply. In addition, all employees are given annual training on specific Code elements to ensure they have a complete understanding of what is expected of them.
Furthermore, as part of procurement training on a sustainable supply chain we reinforce the importance of understanding the risks of modern slavery and human trafficking in our supply chains and our business. We also require our business partners to provide training to their own staff, suppliers and providers.
In order to maintain and continually improve supplier and subcontractor performance we:
Our actions as described above support the Thermo Fisher Scientific long-term commitment to respect the human rights of all people and to improve the quality of life in the communities we serve.
Back to top
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
For more information, please visit www.thermofisher.com
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 90,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.
For more information, please visit
© Copyright 2006-2023 Thermo Fisher Scientific Inc.
All rights reserved.
© Copyright 2006-2023 Thermo Fisher Scientific Inc. All rights reserved.